WILLIAM WONG to Liver Cirrhosis
This is a "connection" page, showing publications WILLIAM WONG has written about Liver Cirrhosis.
Connection Strength
1.156
-
Health care costs associated with chronic hepatitis C virus infection in Ontario, Canada: a retrospective cohort study. CMAJ Open. 2021 Jan-Mar; 9(1):E167-E174.
Score: 0.423
-
Disease burden of chronic hepatitis B among immigrants in Canada. Can J Gastroenterol. 2013 Mar; 27(3):137-47.
Score: 0.242
-
Impact of new direct-acting antiviral therapy on the prevalence and undiagnosed proportion of chronic hepatitis C infection. Liver Int. 2024 Jun; 44(6):1383-1395.
Score: 0.130
-
Cost-effectiveness analysis of sofosbuvir and velpatasvir in chronic hepatitis C patients with decompensated cirrhosis. J Viral Hepat. 2021 02; 28(2):260-267.
Score: 0.103
-
Estimation of fibrosis progression rates for chronic hepatitis C: a systematic review and meta-analysis update. BMJ Open. 2019 11 11; 9(11):e027491.
Score: 0.096
-
Cost Effectiveness of Hepatocellular Carcinoma Surveillance?After a Sustained Virologic Response to Therapy?in Patients With Hepatitis C Virus Infection and Advanced Fibrosis. Clin Gastroenterol Hepatol. 2019 08; 17(9):1840-1849.e16.
Score: 0.091
-
Hepatitis B virus screening before adjuvant chemotherapy in patients with early-stage breast cancer: a cost-effectiveness analysis. Breast Cancer Res Treat. 2015 Jun; 151(3):639-52.
Score: 0.071